Mustang Bio (MBIO) Competitors $1.75 +0.19 (+12.18%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$1.74 -0.01 (-0.86%) As of 10/7/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBIO vs. NBRV, SCYX, TELO, ESLA, IPSC, RNXT, BTAI, OTLK, CALC, and GRCEShould you be buying Mustang Bio stock or one of its competitors? The main competitors of Mustang Bio include Nabriva Therapeutics (NBRV), SCYNEXIS (SCYX), Telomir Pharmaceuticals (TELO), Estrella Immunopharma (ESLA), Century Therapeutics (IPSC), RenovoRx (RNXT), BioXcel Therapeutics (BTAI), Oncobiologics (OTLK), CalciMedica (CALC), and Grace Therapeutics (GRCE). These companies are all part of the "pharmaceutical products" industry. Mustang Bio vs. Its Competitors Nabriva Therapeutics SCYNEXIS Telomir Pharmaceuticals Estrella Immunopharma Century Therapeutics RenovoRx BioXcel Therapeutics Oncobiologics CalciMedica Grace Therapeutics Mustang Bio (NASDAQ:MBIO) and Nabriva Therapeutics (NASDAQ:NBRV) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership. Does the media refer more to MBIO or NBRV? In the previous week, Mustang Bio's average media sentiment score of 1.00 beat Nabriva Therapeutics' score of -0.71 indicating that Mustang Bio is being referred to more favorably in the media. Company Overall Sentiment Mustang Bio Positive Nabriva Therapeutics Negative Do insiders & institutionals hold more shares of MBIO or NBRV? 10.0% of Mustang Bio shares are held by institutional investors. Comparatively, 0.3% of Nabriva Therapeutics shares are held by institutional investors. 0.2% of Mustang Bio shares are held by insiders. Comparatively, 1.6% of Nabriva Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has higher earnings and valuation, MBIO or NBRV? Mustang Bio has higher earnings, but lower revenue than Nabriva Therapeutics. Mustang Bio is trading at a lower price-to-earnings ratio than Nabriva Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMustang BioN/AN/A-$15.75M-$78.00-0.02Nabriva Therapeutics$35.59M0.00-$57.19M-$19.20N/A Which has more risk and volatility, MBIO or NBRV? Mustang Bio has a beta of 2.29, indicating that its stock price is 129% more volatile than the S&P 500. Comparatively, Nabriva Therapeutics has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Do analysts prefer MBIO or NBRV? Given Nabriva Therapeutics' higher possible upside, analysts plainly believe Nabriva Therapeutics is more favorable than Mustang Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mustang Bio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Nabriva Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MBIO or NBRV more profitable? Mustang Bio has a net margin of 0.00% compared to Nabriva Therapeutics' net margin of -148.11%. Mustang Bio's return on equity of 0.00% beat Nabriva Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Mustang BioN/A N/A -29.49% Nabriva Therapeutics -148.11%-365.53%-135.81% SummaryMustang Bio beats Nabriva Therapeutics on 8 of the 13 factors compared between the two stocks. Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBIO vs. The Competition Export to ExcelMetricMustang BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.29M$3.35B$6.12B$10.65BDividend YieldN/A2.29%5.70%4.75%P/E Ratio-0.0221.4185.6026.85Price / SalesN/A466.25612.81135.13Price / CashN/A47.6737.7861.77Price / Book-0.8310.0613.256.70Net Income-$15.75M-$52.22M$3.30B$276.44M7 Day Performance11.46%4.25%3.87%2.48%1 Month Performance28.68%12.50%8.33%8.79%1 Year Performance-83.51%26.68%88.97%34.41% Mustang Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBIOMustang Bio0.926 of 5 stars$1.75+12.2%N/A-84.6%$11.29MN/A-0.02100Positive NewsGap UpHigh Trading VolumeNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070SCYXSCYNEXIS0.6802 of 5 stars$1.05-2.3%N/A-46.8%$45.07M$3.75M-2.6260TELOTelomir Pharmaceuticals3.1463 of 5 stars$1.34-3.6%$15.00+1,019.4%-67.0%$44.87MN/A-2.481News CoverageShort Interest ↓Gap UpESLAEstrella Immunopharma2.5551 of 5 stars$1.19-0.8%$16.00+1,244.5%+13.5%$44.48MN/A-4.58N/AIPSCCentury Therapeutics2.4388 of 5 stars$0.50-1.9%$3.75+650.6%-62.3%$43.98M$6.59M-1.72170News CoverageGap UpRNXTRenovoRx1.7586 of 5 stars$1.18flat$7.50+535.6%+14.0%$43.24M$662K-3.116BTAIBioXcel Therapeutics4.3845 of 5 stars$2.62-3.0%$39.75+1,417.2%-71.6%$43.22M$2.27M-0.2190Positive NewsOTLKOncobiologics2.9083 of 5 stars$1.06+9.3%$7.00+560.4%-77.1%$43.09MN/A-1.8620High Trading VolumeCALCCalciMedica1.9108 of 5 stars$3.09+0.3%$16.00+417.8%-14.4%$43.03MN/A-1.9330Positive NewsGRCEGrace Therapeutics2.0522 of 5 stars$2.97-3.9%$12.00+304.0%N/A$42.73MN/A-3.45N/APositive NewsShort Interest ↑ Related Companies and Tools Related Companies NBRV Alternatives SCYX Alternatives TELO Alternatives ESLA Alternatives IPSC Alternatives RNXT Alternatives BTAI Alternatives OTLK Alternatives CALC Alternatives GRCE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBIO) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mustang Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
